AnjeeDavis

President of @FightCRC. Passionate about community engagement, patient empowerment, and social good. #crcadvocacy #CancerSurvivor 💪🏽 #RelentlessChampions

[AnjeeDavis @AnjeeDavis]

Cancer research is not a line item. It’s a lifeline. 🔬
@ZEROcancer, @FightCRC, @LUNGevity, @PanCAN, @AACI_Cancer + @SusanGKomen join forces to urge sustained federal funding that fuels progress + saves lives.
Read the special co-authored Commentary 🔗 https://t.co/Zmzo3KiQU6

[Fight Colorectal Cancer @FightCRC]

We're rallying 500 climbers across the country to show that #NoOneClimbsAlone.

So let's do this together.

You can join from anywhere:
✔️ Stairs
✔️ Trails
✔️ Treadmills
✔️ Neighborhood walks

Register for #ClimbForACure before July 1: https://t.co/bTmkEkz8X5

[Fight Colorectal Cancer @FightCRC]

Our #ClinicalTrials Newsletter delivers the latest #colorectalcancer updates, expert insights, & clinical trial highlights straight to your inbox—explore the information that matters most to you, all in one place 📫

Thank you to our sponsors 💙: @Merck @JNJNews @bmsnews @SMMT_TX

[Fight Colorectal Cancer @FightCRC]

Turn your story into action. 📣 Join our upcoming Advocacy Action Hour on July 16 at 8:30 PM ET to learn how to work with local media, write a media pitch, and amplify your advocacy beyond social media.

Register now: https://t.co/tCpgrjiI1O

[AnjeeDavis @AnjeeDavis]

Don't let Congress Leave CRC Research Behind! https://t.co/4bQPl8pd8J

[Fight Colorectal Cancer @FightCRC]

500 climbers needed nationwide by July 1.
Join #climbforacure from anywhere:
💪 Free to join
💪 No travel required
💪 Climb your way
💪 Raise $250 for research
Stairs. Hills. Trails. Treadmills. Your climb counts.
https://t.co/bTmkEkz8X5

[AnjeeDavis @AnjeeDavis]

I just donated to @FightCRC ! my goal is to rally an additional $250!!! Will you join me in supporting our team! https://t.co/AigphApbbo

[Fight Colorectal Cancer @FightCRC]

Tomorrow at 1 PM ET: Fight CRC's Research Highlights from @ASCO webinar.

Join @ChrisCannMD of @FoxChaseCancer & @ARosen380 for a discussion of promising #clinicaltrial results, advances in precision medicine, & emerging #CRC research.

Register now: https://t.co/3YXnoFhptc

[Fight Colorectal Cancer @FightCRC]

New research. New possibilities. 💪

We've rounded up the most important #colorectalcancer findings from #ASCO2026 and what they could mean for patients, survivors, and caregivers.

Read the recap: https://t.co/OLsJc6siqv
@ASCO

[AnjeeDavis @AnjeeDavis]

For Phuong, We Keep Fighting https://t.co/ttehRkE8Cf via @LinkedIn @FightCRC @CancerInsider

[Allison Rosen, MS @ARosen380]

Always great to listen to @KimmieNgMD She discussed the Coming Wave of Early-Onset Cancer. With it on the rise we need to do more for these patients. A dedicated program can help with coordination of supportive care service like fertility preservation! @ASCO #ASCO26 @FightCRC

[Fight Colorectal Cancer @FightCRC]

We need 500 climbers by July 1.

#Climbforacure is going nationwide, and you can join from anywhere.

Free to join. No travel required. Climb your way.

Register today: https://t.co/bTmkEkz8X5

[Amylou Dueck, PhD @BiostatGirl]

Come talk to me about patient-reported outcomes! See results of PROs in the ATOMIC A021502 trial - Atezolizumab+mFOLFOX6 vs mFOLFOX6 for adjuvant colon cancer. #ASCO26 @ALLIANCE_org

[Manju George MVSc PhD @manjuggm]

We all need to do more to incorporate structured exercise program as an affordable & available option to #CRC patients. Thank you for all your work! @CDNCancerTrials Dr. Chris Booth @GillSharlene #ASCO26 #CHALLENGE #CRCSM

[AnjeeDavis @AnjeeDavis]

So proud of @JJSingleton1 for always bravely and authentically sharing his story to ground us that the science represents real lives (people we love) 💪🏽💙💪🏽 @fightcrc @ColonCancerCoal @StupidCancer #asco26

[Dr. Cathy Eng @CathyEngMD]

#ASCO26 Abs LBA #3508: EPISODE-III (JCOG 1503C) randomizes ONLY stage III #coloncancer pts to ASA 100 mg x 3 yrs vs. placebo post adjuvant chemo. Primary endpoint = DFS. #cancer #cancerresearch @OncoAlert
Differs vs. ALASCAA trial (Martling et al; NEJM, 2025)
EPISODE-III
👉Stage III colon
👉PIK3CA MT was not required (PIK3CA MT analysis is ongoing)
👉Adjuvant therapy was required
🛑 In unselected patients, ASA 100 mg was not beneficial for DFS

[Allison Rosen, MS @ARosen380]

Kicking off the day at @ASCO with a talk discussing the role of ctDNA across the spectrum of cancer care from early detection to treatment by Valsamo Anagnostou of @HopkinsKimmel!

#ASCO26 #FightCRCRats #cancer @OncoAlert

[AnjeeDavis @AnjeeDavis]

@ARosen380 @FightCRC @MSKCancerCenter @ASCO @OncoAlert Brilliant post

[Allison Rosen, MS @ARosen380]

🚨HOT TOPIC: Multicancer Early Detection: Potential Versus Proof results by Mark Robson MD @MSKCancerCenter.

As an advocate do I tell patients to ask for it based on these results? Thoughts are welcome! #CRCTwitter #GITwitter #ASCO26 #FightCRCRats

@ASCO @FightCRC @OncoAlert

[AnjeeDavis @AnjeeDavis]

Oh my goodness…#asco26 had amazing and brilliant @paltown1 research advocates! loved seeing you 💙 @fightcrc @manjuggm

[AnjeeDavis @AnjeeDavis]

Thank you so much to the @ColonCancerCoal for their steadfast commitment to collaboration and fighting this disease together 💙 appreciate you so much!!! @EKPPRMPLS and Chris Evans 💙 #strongertogether @fightcrc